Stockreport

Pyxis Oncology Announces $50 Million Private Placement

Pyxis Oncology, Inc.  (PYXS) 
PDF BOSTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to [Read more]